vs
Side-by-side financial comparison of NELNET INC (NNI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
NELNET INC is the larger business by last-quarter revenue ($33.5M vs $18.3M, roughly 1.8× ROCKWELL MEDICAL, INC.). NELNET INC runs the higher net margin — 172.3% vs -3.0%, a 175.3% gap on every dollar of revenue. On growth, NELNET INC posted the faster year-over-year revenue change (79.6% vs -25.6%). NELNET INC produced more free cash flow last quarter ($396.7M vs $2.2M). Over the past eight quarters, NELNET INC's revenue compounded faster (62.0% CAGR vs -10.1%).
Nelnet, Inc. is a United States–based conglomerate that primarily focuses on financial services including student and consumer loan origination and servicing. Additionally, the company operates an investing arm, an internet bank and has a 26% stake in Allo Fiber, a cable and internet provider. The company is headquartered in Lincoln, Nebraska.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NNI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.5M | $18.3M |
| Net Profit | $57.8M | $-554.0K |
| Gross Margin | 50.5% | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 172.3% | -3.0% |
| Revenue YoY | 79.6% | -25.6% |
| Net Profit YoY | -8.5% | 26.7% |
| EPS (diluted) | $1.62 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.5M | $18.3M | ||
| Q3 25 | $23.2M | $15.9M | ||
| Q2 25 | $26.1M | $16.1M | ||
| Q1 25 | $24.7M | $18.9M | ||
| Q4 24 | $18.7M | $24.7M | ||
| Q3 24 | $16.6M | $28.3M | ||
| Q2 24 | $14.9M | $25.8M | ||
| Q1 24 | $12.8M | $22.7M |
| Q4 25 | $57.8M | $-554.0K | ||
| Q3 25 | $106.7M | $-1.8M | ||
| Q2 25 | $181.5M | $-1.5M | ||
| Q1 25 | $82.6M | $-1.5M | ||
| Q4 24 | $63.2M | $-756.0K | ||
| Q3 24 | $2.4M | $1.7M | ||
| Q2 24 | $45.1M | $343.0K | ||
| Q1 24 | $73.4M | $-1.7M |
| Q4 25 | 50.5% | 21.1% | ||
| Q3 25 | 29.6% | 14.3% | ||
| Q2 25 | 29.8% | 15.6% | ||
| Q1 25 | 30.5% | 16.1% | ||
| Q4 24 | 13.7% | 14.7% | ||
| Q3 24 | 0.1% | 22.0% | ||
| Q2 24 | 27.3% | 17.6% | ||
| Q1 24 | 15.3% | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | 97.7% | -2.1% | ||
| Q3 24 | -13.4% | 6.8% | ||
| Q2 24 | 88.0% | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 172.3% | -3.0% | ||
| Q3 25 | 460.5% | -11.0% | ||
| Q2 25 | 694.9% | -9.3% | ||
| Q1 25 | 334.4% | -8.0% | ||
| Q4 24 | 338.2% | -3.1% | ||
| Q3 24 | 14.4% | 5.9% | ||
| Q2 24 | 303.6% | 1.3% | ||
| Q1 24 | 574.4% | -7.6% |
| Q4 25 | $1.62 | $-0.01 | ||
| Q3 25 | $2.94 | $-0.05 | ||
| Q2 25 | $4.97 | $-0.05 | ||
| Q1 25 | $2.26 | $-0.04 | ||
| Q4 24 | $1.74 | $-0.02 | ||
| Q3 24 | $0.07 | $0.04 | ||
| Q2 24 | $1.23 | $0.01 | ||
| Q1 24 | $1.98 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $296.0M | $10.7M |
| Total DebtLower is stronger | $7.8B | — |
| Stockholders' EquityBook value | $3.7B | $37.0M |
| Total Assets | $14.1B | $57.1M |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $296.0M | $10.7M | ||
| Q3 25 | $216.4M | $13.6M | ||
| Q2 25 | $225.8M | $12.5M | ||
| Q1 25 | $220.5M | $11.4M | ||
| Q4 24 | $194.5M | $15.7M | ||
| Q3 24 | $219.7M | $12.3M | ||
| Q2 24 | $145.5M | $11.9M | ||
| Q1 24 | $179.7M | $6.6M |
| Q4 25 | $7.8B | — | ||
| Q3 25 | $7.8B | — | ||
| Q2 25 | $7.9B | — | ||
| Q1 25 | $8.7B | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | $8.9B | — | ||
| Q2 24 | $9.6B | — | ||
| Q1 24 | $10.6B | — |
| Q4 25 | $3.7B | $37.0M | ||
| Q3 25 | $3.7B | $37.0M | ||
| Q2 25 | $3.6B | $30.4M | ||
| Q1 25 | $3.4B | $31.5M | ||
| Q4 24 | $3.3B | $32.6M | ||
| Q3 24 | $3.3B | $29.1M | ||
| Q2 24 | $3.3B | $23.5M | ||
| Q1 24 | $3.3B | $20.6M |
| Q4 25 | $14.1B | $57.1M | ||
| Q3 25 | $13.9B | $57.5M | ||
| Q2 25 | $13.7B | $52.6M | ||
| Q1 25 | $14.2B | $54.0M | ||
| Q4 24 | $13.8B | $59.2M | ||
| Q3 24 | $14.1B | $57.1M | ||
| Q2 24 | $14.5B | $53.0M | ||
| Q1 24 | $15.4B | $50.7M |
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.48× | — | ||
| Q3 24 | 2.72× | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | 3.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $423.0M | $2.3M |
| Free Cash FlowOCF − Capex | $396.7M | $2.2M |
| FCF MarginFCF / Revenue | 1183.0% | 12.0% |
| Capex IntensityCapex / Revenue | 78.2% | 0.5% |
| Cash ConversionOCF / Net Profit | 7.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $663.4M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $423.0M | $2.3M | ||
| Q3 25 | $112.4M | $-1.3M | ||
| Q2 25 | $81.8M | $1.8M | ||
| Q1 25 | $91.2M | $-3.5M | ||
| Q4 24 | $662.9M | $865.0K | ||
| Q3 24 | $137.0M | $4.3M | ||
| Q2 24 | $133.8M | $1.4M | ||
| Q1 24 | $211.6M | $-2.4M |
| Q4 25 | $396.7M | $2.2M | ||
| Q3 25 | $100.8M | $-1.5M | ||
| Q2 25 | $78.1M | $1.7M | ||
| Q1 25 | $87.8M | $-3.5M | ||
| Q4 24 | $642.0M | $470.0K | ||
| Q3 24 | $132.6M | $4.1M | ||
| Q2 24 | $123.1M | $1.2M | ||
| Q1 24 | $188.3M | $-2.5M |
| Q4 25 | 1183.0% | 12.0% | ||
| Q3 25 | 435.0% | -9.6% | ||
| Q2 25 | 299.0% | 10.5% | ||
| Q1 25 | 355.6% | -18.8% | ||
| Q4 24 | 3438.0% | 1.9% | ||
| Q3 24 | 797.9% | 14.4% | ||
| Q2 24 | 829.2% | 4.5% | ||
| Q1 24 | 1473.7% | -11.1% |
| Q4 25 | 78.2% | 0.5% | ||
| Q3 25 | 50.4% | 1.4% | ||
| Q2 25 | 14.2% | 1.0% | ||
| Q1 25 | 13.7% | 0.3% | ||
| Q4 24 | 111.9% | 1.6% | ||
| Q3 24 | 26.7% | 0.7% | ||
| Q2 24 | 71.5% | 1.1% | ||
| Q1 24 | 181.7% | 0.6% |
| Q4 25 | 7.32× | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 0.45× | — | ||
| Q1 25 | 1.10× | — | ||
| Q4 24 | 10.50× | — | ||
| Q3 24 | 57.39× | 2.57× | ||
| Q2 24 | 2.97× | 4.20× | ||
| Q1 24 | 2.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NNI
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
